| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $249.3M | -2.0% |
| R&D Expense | $72.9M | -15.3% |
| SG&A Expense | $88.0M | -27.3% |
| Operating Income | -$105.3M | +51.6% |
| Pre-tax Income | -$94.5M | +55.0% |
| Income Tax | $434K | -84.2% |
| Net Income | -$95.7M | +54.0% |
| EPS (Basic) | -$5.96 | +57.1% |
| EPS (Diluted) | -$5.96 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $182.3M | -20.1% |
| Accounts Receivable | $49.7M | -30.9% |
| Inventory | $1.2M | -58.5% |
| Current Assets | $246.7M | -22.2% |
| Total Assets | $323.8M | -25.7% |
| Current Liabilities | $73.2M | -34.2% |
| Total Liabilities | $76.0M | -36.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.0M | +48.2% |
| Capital Expenditures | $21K | -82.4% |
| Investing Cash Flow | $17.1M | +191.7% |
| Financing Cash Flow | $840K | -39.2% |
| Free Cash Flow | -$66.0M | +48.2% |
| +57.1% |
| Stockholders' Equity |
| $235.6M |
| -22.7% |